Deoxycholic acid (DCA) and lithocholic acid (LCA) are secondary BAs that decrease the activity of the farnesoid X receptor (FXR); it is a nuclear receptor that has a tumor-suppressive effect and is involved in the development of CRC [58,78]. This evidence concerns the gene NR1H4 and colorectal carcinoma.